Skip to Main Content
Insider Trading

John James Sullivan Net Worth

Track Major Insider Updates On X/Twitter

Last Updated: 2 days, 11 hours ago

John James Sullivan has an estimated net worth of at least $13.6 million*, as of April 23, 2025. They own 70,658 shares of MLAB stock. They have sold 31,925 shares of MLAB stock since 2021, for an estimated $5.4 million.

John James Sullivan $MLAB SEC Form 4 Insider Trading

John James Sullivan has filed a total of 7 insider trades in $MLAB since 2021. Their most recent trade was a sale of 5,192 shares, made on Jun 07, 2022. Their largest trade was a sale of 5,192 shares, made on Jun 07, 2022. We estimate that they now own 70,658 shares of $MLAB, worth an estimated $8.3 million.



Insider Trading at $MLAB

There have been a total of 60 insider trades reported at $MLAB since 2021, with 500 shares purchased and 114,625 shares sold. The most active insider traders in $MLAB stock have been John Sakys, Gary M Owens, and Brian David Archbold. The most recent trade was a sale of 21,000 shares reported by Gary M Owens (President and CEO), made on Mar 19, 2025.



History of Insider Stock Trades by John James Sullivan

Company Ticker Purchase / Sale Shares Date Disclosed (EST)
MLAB logo MLAB Sale 5,192 Jun 07, 2022 June 13, 2022, 9:09 a.m.
MLAB logo MLAB Sale 5,192 Feb 15, 2022 Feb. 16, 2022, 3:10 p.m.
MLAB logo MLAB Sale 5,192 Nov 15, 2021 Nov. 16, 2021, 12:47 p.m.
MLAB logo MLAB Sale 1,250 Oct 01, 2021 Oct. 3, 2021, 8 p.m.
mlab logo mlab Sale 5,192 Aug 16, 2021 Aug. 16, 2021, 8 p.m.
MLAB logo MLAB Sale 1,250 Aug 02, 2021 Aug. 1, 2021, 8 p.m.
MLAB logo MLAB Sale 1,250 Jul 01, 2021 July 5, 2021, 8 p.m.
MLAB logo MLAB Sale 5,192 Jun 08, 2021 June 8, 2021, 8 p.m.
mlab logo mlab Sale 2,215 Jun 01, 2021 June 3, 2021, 8 p.m.




$MLAB Executives and Stock Owners with Insider Trades



*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.